Scientists track hearing loss in kids to unlock future treatments
NCT ID NCT05402813
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 180 children up to age 16 who have hearing loss caused by mutations in the GJB2 or OTOF genes. Researchers will regularly measure their hearing using standard tests and questionnaires to see how it changes over time. The goal is to better understand the natural course of these conditions, which could help in planning future clinical trials for new therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study will provide crucial data on how genetic hearing loss progresses in children, which could help design future treatments.
- What could go wrong
- This is an observational study, not testing any treatment. It may not lead directly to new therapies, and results depend on consistent follow-up over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUNB1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker Hospital
RECRUITINGParis, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gene therapy restore natural hearing after cochlear implants?
- One-Time injection aims to restore hearing in children born deaf
- One-time gene therapy aims to restore hearing in kids with genetic deafness
- New tuning method could help cochlear implant users hear better in noise
- Scientists track hearing decline in adults with genetic mutation
- New cochlear tweak may help you hear in crowds